Impacto dos Biossimilares no Tratamento da Psoríase

Tiago Torres; Paulo Filipe; Manuela Selores

doi:10.20344/amp.5001

Impact of Biosimilars in Psoriasis Treatment

Authors

Tiago Torres Service of Dermatology. Centro Hospitalar do Porto. Porto. Portugal. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.
Paulo Filipe Psoriasis Appointments. Service of Dermatology. Centro Hospitalar Lisboa Norte. Lisboa. Portugal. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal. Investigation Unit of Dermatology. Instituto de Medicina Molecular. Universidade de Lisboa. Lisboa. Portugal.
Manuela Selores Service of Dermatology. Centro Hospitalar do Porto. Porto. Portugal. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.

DOI:

https://doi.org/10.20344/amp.5001

Abstract

Downloads

Download data is not yet available.

Author Biographies

Tiago Torres, Service of Dermatology. Centro Hospitalar do Porto. Porto. Portugal. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.

Paulo Filipe, Psoriasis Appointments. Service of Dermatology. Centro Hospitalar Lisboa Norte. Lisboa. Portugal. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Portugal. Investigation Unit of Dermatology. Instituto de Medicina Molecular. Universidade de Lisboa. Lisboa. Portugal.

Manuela Selores, Service of Dermatology. Centro Hospitalar do Porto. Porto. Portugal. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.

Downloads

Published

2013-12-20

How to Cite

Torres T, Filipe P, Selores M. Impact of Biosimilars in Psoriasis Treatment. Acta Med Port [Internet]. 2013 Dec. 20 [cited 2024 Nov. 22];26(6):646-8. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/5001

Download Citation

Issue

Vol. 26 No. 6 (2013): November-December

Section

Perspective

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.